Stay updated on Nivolumab and Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s site revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or platform update rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T06:09:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Melanoma as a topic and related topics (MedlinePlus Genetics); updated revision to v3.5.2 and removed v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:46:09.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The Italy site entry was updated from Padua, Italy 35128 to Padova, Italy 35128.
    Difference
    0.0%
    Check dated 2026-04-09T21:43:36.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The Melanoma topic, related topics, and MedlinePlus Genetics were removed from the page.
    Difference
    0.1%
    Check dated 2026-04-02T15:33:23.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Naples, Italy, 80131 was added as a location and Napoli, Italy, 80131 was removed; Melanoma and related topics, including MedlinePlus Genetics, were added to the related topics section.
    Difference
    0.1%
    Check dated 2026-03-26T11:37:47.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0; the previous v3.4.3 label was removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:15:33.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.